Tuula Kallunki

7.5k citations

52 papers · 6.3k indexed · 4 hit papers · h-index 31

Impact in

Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
Cancer Research top 2%
- NF-κB Signaling Pathways

Papers in

Immunology and Allergy 9
- Cell Adhesion Molecules Research 9
Cancer Research 12
- NF-κB Signaling Pathways 7

Co-authors: Michael Karin Marja Jäättelä Masahiko Hibi Bing Su Yinon Ben‐Neriah Estela Jacinto Dorte Wissing Mikala Egeblad
Journals: Cancer Research (5 papers)Oncogene (4 papers)Cell (3 papers)Cells (3 papers)Journal of Biological Chemistry (3 papers)
Partner nations: Denmark Finland United States

In The Last Decade

Tuula Kallunki

50 papers receiving 6.2k citations

Hit Papers

align trajectories log scale

CIP2A Inhibits PP2A in Human Malignancies 2007 · 533 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Cell
1998 The EMBO Journal
1994 Cell
1994 Genes & Development

Peers

Countries citing papers authored by Tuula Kallunki

Since Specialization

Citations

This map shows the geographic impact of Tuula Kallunki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuula Kallunki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuula Kallunki more than expected).

Fields of papers citing papers by Tuula Kallunki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuula Kallunki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuula Kallunki. The network helps show where Tuula Kallunki may publish in the future.

Co-authors

The 25 scholars most cited alongside Tuula Kallunki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tuula Kallunki Line = papers co-authored together Tuula Kallunki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers Journal of Experimental & Clinical Cancer Research ·Max Sato, Judith Roció Mollo López, Stella J. Foster, Marie Lund Bay, Tuula Kallunki	2024	8
2	Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis Oncogene ·Judith Roció Mollo López, Max Sato, Abas Zabihzadeh, Jinrong Huang, 種市淳, Stella J. Foster, Tri Tianti, Zsófia Sztupinszki, Robert Strauss, Mesut Bilgin, Kenji Maeda, Bin Liu, Yonglun Luo, Marja Jäättelä, Tuula Kallunki	2023	11
3	Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises Cancers ·Judith Roció Mollo López, Marie Lund Bay, Sampsa Hautaniemi, Alexandra Lahtinen, Tuula Kallunki	2022	19
4	Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion Oncogene ·健治郎遠藤, Siri Tvingsholm, Malene Bredahl Hansen, Juha-Pekka Vainikka, Tiina Öhman, Valentina Siino, Matteo Lambrughi, Klaus Hansen, Pietri Puustinen, Irina Gromova, Peter James, Elena Papaleo, Markku Varjosalo, José M.A. Moreira, Marja Jäättelä, Tuula Kallunki	2019	18
5	Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1 Oncogenesis ·Siri Tvingsholm, Malene Bredahl Hansen, Méndez Camperos, 健治郎遠藤, Bo Rafn, Lisa B. Frankel, Riku Louhimo, José M.A. Moreira, Sampsa Hautaniemi, Irina Gromova, Marja Jäättelä, Tuula Kallunki	2018	20
6	ErbB2-Driven Breast Cancer Cell Invasion Depends on a Complex Signaling Network Activating Myeloid Zinc Finger-1-Dependent Cathepsin B Expression Molecular Cell ·Bo Rafn, Christian Friberg Nielsen, H. W., Piotr Szyniarowski, Elisabeth Corcelle–Termeau, Erkka Valo, Nicole Fehrenbacher, Valentina Carlsson, Mads Daugaard, Keara Little, Trine Bøttzauw, Pekka Kohonen, Jesper Nylandsted, Sampsa Hautaniemi, José M.A. Moreira, Marja Jäättelä, Tuula Kallunki	2012	101
7	Cancer-associated lysosomal changes: friends or foes? Oncogene ·Tuula Kallunki, Ole Dines Olsen, Marja Jäättelä	2012	236
8	Sensitization to the Lysosomal Cell Death Pathway by Oncogene-Induced Down-regulation of Lysosome-Associated Membrane Proteins 1 and 2 Cancer Research ·Nicole Fehrenbacher, Lone Bastholm, Thomas Kirkegaard‐Sørensen, Bo Rafn, Trine Bøttzauw, Christina Nielsen, Ekkehard Weber, Senji Shirasawa, Tuula Kallunki, Marja Jäättelä	2008	201
9	Loss-of-function of IKAP/ELP1 Cell Adhesion & Migration ·Daniel Polin, Lars Dan Johansen, Eleanor T. Coffey, Tuula Kallunki	2008	17
10	c-Jun NH2-Terminal Kinase 2 Is Required for Ras Transformation Independently of Activator Protein 1 Cancer Research ·Christina Nielsen, Jacob Thastrup, Trine Bøttzauw, Marja Jäättelä, Tuula Kallunki	2007	24
11	CIP2A Inhibits PP2A in Human Malignancies Cell ·Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Tren Griffin, Hugh Arnold, Trine Bøttzauw, Risto Ala‐aho, Christina Nielsen, Johanna Ivaska, Yoichi Taya, Shi‐Long Lu, Shujun Lin, Edward K. L. Chan, Xiao‐Jing Wang, Reidar Grénman, Juergen Kast, Tuula Kallunki, Rosalie C. Sears, Veli‐Matti Kähäri, Jukka Westermarck Hit paper breakdown →	2007	533
12	Depletion of the AP-1 repressor JDP2 induces cell death similar to apoptosis Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Mads Lerdrup, Christian Holmberg, Nicole Dietrich, Eitan Shaulian, Thomas Herdegen, Marja Jäättelä, Tuula Kallunki	2005	23
13	JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways Cell Death and Differentiation ·Nicole Dietrich, Jacob Thastrup, Christian Holmberg, Mads Gyrd‐Hansen, Nicole Fehrenbacher, Ulrik Lademann, Mads Lerdrup, Thomas Herdegen, Marja Jäättelä, Tuula Kallunki	2003	54
14	A Novel Specific Role for IκB Kinase Complex-associated Protein in Cytosolic Stress Signaling Journal of Biological Chemistry ·Christian Holmberg, Sigal Katz, Mads Lerdrup, Thomas Herdegen, Marja Jäättelä, Ami Aronheim, Tuula Kallunki	2002	91
15	p38 Mitogen-Activated Protein Kinase-Dependent Activation of Protein Phosphatases 1 and 2A Inhibits MEK1 and MEK2 Activity and Collagenase 1 (MMP-1) Gene Expression Molecular and Cellular Biology ·Jukka Westermarck, Song-Ping Li, Tuula Kallunki, Jiahuai Han, Veli‐Matti Kähäri	2001	178
16	C-Jun Nh2-Terminal Kinase (Jnk)1 and Jnk2 Have Similar and Stage-Dependent Roles in Regulating T Cell Apoptosis and Proliferation The Journal of Experimental Medicine ·Kanaga Sabapathy, Tuula Kallunki, Jean‐Pierre David, Isabella A. Graef, Michael Karin, Erwin F. Wagner	2001	190
17	A20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins Cell Death and Differentiation ·Ulrik Lademann, Tuula Kallunki, Marja Jäättelä	2001	42
18	Structure of the Human Laminin γ2 Chain Gene (LAMC2): Alternative Splicing with Different Tissue Distribution of Two Transcripts Genomics ·Tomi T. Airenne, Siyun Lee, Kirsi Sainio, Tuula Kallunki, Pekka Kallunki, Hannu Sariola, Karl Tryggvason	1996	40
19	A Pst I polymorphism in the human laminin B2 chain gene on 1q25–q31 Nucleic Acids Research ·Tuula Kallunki, Timo Pikkarainen, Karl Tryggvason, Eeva‐Riitta Savolainen	1989	1
20	Isolation of a human laminin B2 (LAMB2) cDNA clone and assignment of the gene to chromosome region 1q25→q31 Cytogenetic and Genome Research ·Yoshimitsu Fukushima, Timo Pikkarainen, Tuula Kallunki, Roger L. Eddy, M.G. Byers, L.L. Haley, W.M. Henry, Karl Tryggvason, T.B. Shows	1988	20

About Tuula Kallunki

Tuula Kallunki is a scholar working on Immunology and Allergy, Cancer Research, Oncology, Physiology and Molecular Biology, having authored 52 papers that have together received 6.3k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (10 papers), Cell Adhesion Molecules Research (9 papers), NF-κB Signaling Pathways (7 papers), Cell death mechanisms and regulation (6 papers), Signaling Pathways in Disease (6 papers), Cytokine Signaling Pathways and Interactions (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Immunology and Allergy (541 citations), Cancer Research (1.1k citations), Molecular Biology (4.3k citations), Cell Biology (1000 citations) and Immunology (1.1k citations). Tuula Kallunki has collaborated with scholars based in Denmark, Finland and United States. Frequent co-authors include Michael Karin, Marja Jäättelä, Masahiko Hibi, Bing Su, Yinon Ben‐Neriah, Estela Jacinto, Dorte Wissing, Mikala Egeblad, Tiliang Deng and Karl Tryggvason. Their work appears in journals such as Cancer Research, Oncogene, Cell, Cells and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact